Global Duchenne Muscular Dystrophy Treatment Supply, Demand and Key Producers, 2023-2029
The global Duchenne Muscular Dystrophy Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Duchenne Muscular Dystrophy Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Duchenne Muscular Dystrophy Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Duchenne Muscular Dystrophy Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Duchenne Muscular Dystrophy Treatment total market, 2018-2029, (USD Million)
Global Duchenne Muscular Dystrophy Treatment total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Duchenne Muscular Dystrophy Treatment total market, key domestic companies and share, (USD Million)
Global Duchenne Muscular Dystrophy Treatment revenue by player and market share 2018-2023, (USD Million)
Global Duchenne Muscular Dystrophy Treatment total market by Type, CAGR, 2018-2029, (USD Million)
Global Duchenne Muscular Dystrophy Treatment total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Duchenne Muscular Dystrophy Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ITALFARMACO SpA, FibroGen, Inc., Summit Therapeuticsplc, PTC Therapeutics, Santhera Pharmaceuticals and Sarepta Therapeutics, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Duchenne Muscular Dystrophy Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Duchenne Muscular Dystrophy Treatment Market, By Region:
1. How big is the global Duchenne Muscular Dystrophy Treatment market?
2. What is the demand of the global Duchenne Muscular Dystrophy Treatment market?
3. What is the year over year growth of the global Duchenne Muscular Dystrophy Treatment market?
4. What is the total value of the global Duchenne Muscular Dystrophy Treatment market?
5. Who are the major players in the global Duchenne Muscular Dystrophy Treatment market?
6. What are the growth factors driving the market demand?
This report studies the global Duchenne Muscular Dystrophy Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Duchenne Muscular Dystrophy Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Duchenne Muscular Dystrophy Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Duchenne Muscular Dystrophy Treatment total market, 2018-2029, (USD Million)
Global Duchenne Muscular Dystrophy Treatment total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Duchenne Muscular Dystrophy Treatment total market, key domestic companies and share, (USD Million)
Global Duchenne Muscular Dystrophy Treatment revenue by player and market share 2018-2023, (USD Million)
Global Duchenne Muscular Dystrophy Treatment total market by Type, CAGR, 2018-2029, (USD Million)
Global Duchenne Muscular Dystrophy Treatment total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Duchenne Muscular Dystrophy Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ITALFARMACO SpA, FibroGen, Inc., Summit Therapeuticsplc, PTC Therapeutics, Santhera Pharmaceuticals and Sarepta Therapeutics, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Duchenne Muscular Dystrophy Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Duchenne Muscular Dystrophy Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- NSAIDs
- Corticosteroids
- Others
- Hospital
- Clinic
- Others
- ITALFARMACO SpA
- FibroGen, Inc.
- Summit Therapeuticsplc
- PTC Therapeutics
- Santhera Pharmaceuticals
- Sarepta Therapeutics, Inc.
1. How big is the global Duchenne Muscular Dystrophy Treatment market?
2. What is the demand of the global Duchenne Muscular Dystrophy Treatment market?
3. What is the year over year growth of the global Duchenne Muscular Dystrophy Treatment market?
4. What is the total value of the global Duchenne Muscular Dystrophy Treatment market?
5. Who are the major players in the global Duchenne Muscular Dystrophy Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Duchenne Muscular Dystrophy Treatment Introduction
1.2 World Duchenne Muscular Dystrophy Treatment Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Duchenne Muscular Dystrophy Treatment Total Market by Region (by Headquarter Location)
1.3.1 World Duchenne Muscular Dystrophy Treatment Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Duchenne Muscular Dystrophy Treatment Market Size (2018-2029)
1.3.3 China Duchenne Muscular Dystrophy Treatment Market Size (2018-2029)
1.3.4 Europe Duchenne Muscular Dystrophy Treatment Market Size (2018-2029)
1.3.5 Japan Duchenne Muscular Dystrophy Treatment Market Size (2018-2029)
1.3.6 South Korea Duchenne Muscular Dystrophy Treatment Market Size (2018-2029)
1.3.7 ASEAN Duchenne Muscular Dystrophy Treatment Market Size (2018-2029)
1.3.8 India Duchenne Muscular Dystrophy Treatment Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Duchenne Muscular Dystrophy Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Duchenne Muscular Dystrophy Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
2.2 World Duchenne Muscular Dystrophy Treatment Consumption Value by Region
2.2.1 World Duchenne Muscular Dystrophy Treatment Consumption Value by Region (2018-2023)
2.2.2 World Duchenne Muscular Dystrophy Treatment Consumption Value Forecast by Region (2024-2029)
2.3 United States Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
2.4 China Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
2.5 Europe Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
2.6 Japan Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
2.7 South Korea Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
2.8 ASEAN Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
2.9 India Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
3 WORLD DUCHENNE MUSCULAR DYSTROPHY TREATMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Duchenne Muscular Dystrophy Treatment Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Duchenne Muscular Dystrophy Treatment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Duchenne Muscular Dystrophy Treatment in 2022
3.2.3 Global Concentration Ratios (CR8) for Duchenne Muscular Dystrophy Treatment in 2022
3.3 Duchenne Muscular Dystrophy Treatment Company Evaluation Quadrant
3.4 Duchenne Muscular Dystrophy Treatment Market: Overall Company Footprint Analysis
3.4.1 Duchenne Muscular Dystrophy Treatment Market: Region Footprint
3.4.2 Duchenne Muscular Dystrophy Treatment Market: Company Product Type Footprint
3.4.3 Duchenne Muscular Dystrophy Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Duchenne Muscular Dystrophy Treatment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Duchenne Muscular Dystrophy Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Duchenne Muscular Dystrophy Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Duchenne Muscular Dystrophy Treatment Consumption Value Comparison
4.2.1 United States VS China: Duchenne Muscular Dystrophy Treatment Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Duchenne Muscular Dystrophy Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Duchenne Muscular Dystrophy Treatment Companies and Market Share, 2018-2023
4.3.1 United States Based Duchenne Muscular Dystrophy Treatment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Duchenne Muscular Dystrophy Treatment Revenue, (2018-2023)
4.4 China Based Companies Duchenne Muscular Dystrophy Treatment Revenue and Market Share, 2018-2023
4.4.1 China Based Duchenne Muscular Dystrophy Treatment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Duchenne Muscular Dystrophy Treatment Revenue, (2018-2023)
4.5 Rest of World Based Duchenne Muscular Dystrophy Treatment Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Duchenne Muscular Dystrophy Treatment Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Duchenne Muscular Dystrophy Treatment Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Duchenne Muscular Dystrophy Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 NSAIDs
5.2.2 Corticosteroids
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Duchenne Muscular Dystrophy Treatment Market Size by Type (2018-2023)
5.3.2 World Duchenne Muscular Dystrophy Treatment Market Size by Type (2024-2029)
5.3.3 World Duchenne Muscular Dystrophy Treatment Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Duchenne Muscular Dystrophy Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Duchenne Muscular Dystrophy Treatment Market Size by Application (2018-2023)
6.3.2 World Duchenne Muscular Dystrophy Treatment Market Size by Application (2024-2029)
6.3.3 World Duchenne Muscular Dystrophy Treatment Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 ITALFARMACO SpA
7.1.1 ITALFARMACO SpA Details
7.1.2 ITALFARMACO SpA Major Business
7.1.3 ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Product and Services
7.1.4 ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 ITALFARMACO SpA Recent Developments/Updates
7.1.6 ITALFARMACO SpA Competitive Strengths & Weaknesses
7.2 FibroGen, Inc.
7.2.1 FibroGen, Inc. Details
7.2.2 FibroGen, Inc. Major Business
7.2.3 FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Product and Services
7.2.4 FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 FibroGen, Inc. Recent Developments/Updates
7.2.6 FibroGen, Inc. Competitive Strengths & Weaknesses
7.3 Summit Therapeuticsplc
7.3.1 Summit Therapeuticsplc Details
7.3.2 Summit Therapeuticsplc Major Business
7.3.3 Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Product and Services
7.3.4 Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Summit Therapeuticsplc Recent Developments/Updates
7.3.6 Summit Therapeuticsplc Competitive Strengths & Weaknesses
7.4 PTC Therapeutics
7.4.1 PTC Therapeutics Details
7.4.2 PTC Therapeutics Major Business
7.4.3 PTC Therapeutics Duchenne Muscular Dystrophy Treatment Product and Services
7.4.4 PTC Therapeutics Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 PTC Therapeutics Recent Developments/Updates
7.4.6 PTC Therapeutics Competitive Strengths & Weaknesses
7.5 Santhera Pharmaceuticals
7.5.1 Santhera Pharmaceuticals Details
7.5.2 Santhera Pharmaceuticals Major Business
7.5.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Product and Services
7.5.4 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Santhera Pharmaceuticals Recent Developments/Updates
7.5.6 Santhera Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Sarepta Therapeutics, Inc.
7.6.1 Sarepta Therapeutics, Inc. Details
7.6.2 Sarepta Therapeutics, Inc. Major Business
7.6.3 Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Product and Services
7.6.4 Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Sarepta Therapeutics, Inc. Recent Developments/Updates
7.6.6 Sarepta Therapeutics, Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Duchenne Muscular Dystrophy Treatment Industry Chain
8.2 Duchenne Muscular Dystrophy Treatment Upstream Analysis
8.3 Duchenne Muscular Dystrophy Treatment Midstream Analysis
8.4 Duchenne Muscular Dystrophy Treatment Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Duchenne Muscular Dystrophy Treatment Introduction
1.2 World Duchenne Muscular Dystrophy Treatment Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Duchenne Muscular Dystrophy Treatment Total Market by Region (by Headquarter Location)
1.3.1 World Duchenne Muscular Dystrophy Treatment Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Duchenne Muscular Dystrophy Treatment Market Size (2018-2029)
1.3.3 China Duchenne Muscular Dystrophy Treatment Market Size (2018-2029)
1.3.4 Europe Duchenne Muscular Dystrophy Treatment Market Size (2018-2029)
1.3.5 Japan Duchenne Muscular Dystrophy Treatment Market Size (2018-2029)
1.3.6 South Korea Duchenne Muscular Dystrophy Treatment Market Size (2018-2029)
1.3.7 ASEAN Duchenne Muscular Dystrophy Treatment Market Size (2018-2029)
1.3.8 India Duchenne Muscular Dystrophy Treatment Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Duchenne Muscular Dystrophy Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Duchenne Muscular Dystrophy Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
2.2 World Duchenne Muscular Dystrophy Treatment Consumption Value by Region
2.2.1 World Duchenne Muscular Dystrophy Treatment Consumption Value by Region (2018-2023)
2.2.2 World Duchenne Muscular Dystrophy Treatment Consumption Value Forecast by Region (2024-2029)
2.3 United States Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
2.4 China Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
2.5 Europe Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
2.6 Japan Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
2.7 South Korea Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
2.8 ASEAN Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
2.9 India Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029)
3 WORLD DUCHENNE MUSCULAR DYSTROPHY TREATMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Duchenne Muscular Dystrophy Treatment Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Duchenne Muscular Dystrophy Treatment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Duchenne Muscular Dystrophy Treatment in 2022
3.2.3 Global Concentration Ratios (CR8) for Duchenne Muscular Dystrophy Treatment in 2022
3.3 Duchenne Muscular Dystrophy Treatment Company Evaluation Quadrant
3.4 Duchenne Muscular Dystrophy Treatment Market: Overall Company Footprint Analysis
3.4.1 Duchenne Muscular Dystrophy Treatment Market: Region Footprint
3.4.2 Duchenne Muscular Dystrophy Treatment Market: Company Product Type Footprint
3.4.3 Duchenne Muscular Dystrophy Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Duchenne Muscular Dystrophy Treatment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Duchenne Muscular Dystrophy Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Duchenne Muscular Dystrophy Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Duchenne Muscular Dystrophy Treatment Consumption Value Comparison
4.2.1 United States VS China: Duchenne Muscular Dystrophy Treatment Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Duchenne Muscular Dystrophy Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Duchenne Muscular Dystrophy Treatment Companies and Market Share, 2018-2023
4.3.1 United States Based Duchenne Muscular Dystrophy Treatment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Duchenne Muscular Dystrophy Treatment Revenue, (2018-2023)
4.4 China Based Companies Duchenne Muscular Dystrophy Treatment Revenue and Market Share, 2018-2023
4.4.1 China Based Duchenne Muscular Dystrophy Treatment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Duchenne Muscular Dystrophy Treatment Revenue, (2018-2023)
4.5 Rest of World Based Duchenne Muscular Dystrophy Treatment Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Duchenne Muscular Dystrophy Treatment Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Duchenne Muscular Dystrophy Treatment Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Duchenne Muscular Dystrophy Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 NSAIDs
5.2.2 Corticosteroids
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Duchenne Muscular Dystrophy Treatment Market Size by Type (2018-2023)
5.3.2 World Duchenne Muscular Dystrophy Treatment Market Size by Type (2024-2029)
5.3.3 World Duchenne Muscular Dystrophy Treatment Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Duchenne Muscular Dystrophy Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Duchenne Muscular Dystrophy Treatment Market Size by Application (2018-2023)
6.3.2 World Duchenne Muscular Dystrophy Treatment Market Size by Application (2024-2029)
6.3.3 World Duchenne Muscular Dystrophy Treatment Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 ITALFARMACO SpA
7.1.1 ITALFARMACO SpA Details
7.1.2 ITALFARMACO SpA Major Business
7.1.3 ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Product and Services
7.1.4 ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 ITALFARMACO SpA Recent Developments/Updates
7.1.6 ITALFARMACO SpA Competitive Strengths & Weaknesses
7.2 FibroGen, Inc.
7.2.1 FibroGen, Inc. Details
7.2.2 FibroGen, Inc. Major Business
7.2.3 FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Product and Services
7.2.4 FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 FibroGen, Inc. Recent Developments/Updates
7.2.6 FibroGen, Inc. Competitive Strengths & Weaknesses
7.3 Summit Therapeuticsplc
7.3.1 Summit Therapeuticsplc Details
7.3.2 Summit Therapeuticsplc Major Business
7.3.3 Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Product and Services
7.3.4 Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Summit Therapeuticsplc Recent Developments/Updates
7.3.6 Summit Therapeuticsplc Competitive Strengths & Weaknesses
7.4 PTC Therapeutics
7.4.1 PTC Therapeutics Details
7.4.2 PTC Therapeutics Major Business
7.4.3 PTC Therapeutics Duchenne Muscular Dystrophy Treatment Product and Services
7.4.4 PTC Therapeutics Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 PTC Therapeutics Recent Developments/Updates
7.4.6 PTC Therapeutics Competitive Strengths & Weaknesses
7.5 Santhera Pharmaceuticals
7.5.1 Santhera Pharmaceuticals Details
7.5.2 Santhera Pharmaceuticals Major Business
7.5.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Product and Services
7.5.4 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Santhera Pharmaceuticals Recent Developments/Updates
7.5.6 Santhera Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Sarepta Therapeutics, Inc.
7.6.1 Sarepta Therapeutics, Inc. Details
7.6.2 Sarepta Therapeutics, Inc. Major Business
7.6.3 Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Product and Services
7.6.4 Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Sarepta Therapeutics, Inc. Recent Developments/Updates
7.6.6 Sarepta Therapeutics, Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Duchenne Muscular Dystrophy Treatment Industry Chain
8.2 Duchenne Muscular Dystrophy Treatment Upstream Analysis
8.3 Duchenne Muscular Dystrophy Treatment Midstream Analysis
8.4 Duchenne Muscular Dystrophy Treatment Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Duchenne Muscular Dystrophy Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Duchenne Muscular Dystrophy Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Duchenne Muscular Dystrophy Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Duchenne Muscular Dystrophy Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Duchenne Muscular Dystrophy Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Duchenne Muscular Dystrophy Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Duchenne Muscular Dystrophy Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Duchenne Muscular Dystrophy Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Duchenne Muscular Dystrophy Treatment Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Duchenne Muscular Dystrophy Treatment Players in 2022
Table 12. World Duchenne Muscular Dystrophy Treatment Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Duchenne Muscular Dystrophy Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Duchenne Muscular Dystrophy Treatment Player
Table 15. Duchenne Muscular Dystrophy Treatment Market: Company Product Type Footprint
Table 16. Duchenne Muscular Dystrophy Treatment Market: Company Product Application Footprint
Table 17. Duchenne Muscular Dystrophy Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Duchenne Muscular Dystrophy Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Duchenne Muscular Dystrophy Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Duchenne Muscular Dystrophy Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Duchenne Muscular Dystrophy Treatment Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Duchenne Muscular Dystrophy Treatment Revenue Market Share (2018-2023)
Table 23. China Based Duchenne Muscular Dystrophy Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Duchenne Muscular Dystrophy Treatment Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Duchenne Muscular Dystrophy Treatment Revenue Market Share (2018-2023)
Table 26. Rest of World Based Duchenne Muscular Dystrophy Treatment Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Duchenne Muscular Dystrophy Treatment Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Duchenne Muscular Dystrophy Treatment Revenue Market Share (2018-2023)
Table 29. World Duchenne Muscular Dystrophy Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Duchenne Muscular Dystrophy Treatment Market Size by Type (2018-2023) & (USD Million)
Table 31. World Duchenne Muscular Dystrophy Treatment Market Size by Type (2024-2029) & (USD Million)
Table 32. World Duchenne Muscular Dystrophy Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Duchenne Muscular Dystrophy Treatment Market Size by Application (2018-2023) & (USD Million)
Table 34. World Duchenne Muscular Dystrophy Treatment Market Size by Application (2024-2029) & (USD Million)
Table 35. ITALFARMACO SpA Basic Information, Area Served and Competitors
Table 36. ITALFARMACO SpA Major Business
Table 37. ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Product and Services
Table 38. ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. ITALFARMACO SpA Recent Developments/Updates
Table 40. ITALFARMACO SpA Competitive Strengths & Weaknesses
Table 41. FibroGen, Inc. Basic Information, Area Served and Competitors
Table 42. FibroGen, Inc. Major Business
Table 43. FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Product and Services
Table 44. FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. FibroGen, Inc. Recent Developments/Updates
Table 46. FibroGen, Inc. Competitive Strengths & Weaknesses
Table 47. Summit Therapeuticsplc Basic Information, Area Served and Competitors
Table 48. Summit Therapeuticsplc Major Business
Table 49. Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Product and Services
Table 50. Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Summit Therapeuticsplc Recent Developments/Updates
Table 52. Summit Therapeuticsplc Competitive Strengths & Weaknesses
Table 53. PTC Therapeutics Basic Information, Area Served and Competitors
Table 54. PTC Therapeutics Major Business
Table 55. PTC Therapeutics Duchenne Muscular Dystrophy Treatment Product and Services
Table 56. PTC Therapeutics Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. PTC Therapeutics Recent Developments/Updates
Table 58. PTC Therapeutics Competitive Strengths & Weaknesses
Table 59. Santhera Pharmaceuticals Basic Information, Area Served and Competitors
Table 60. Santhera Pharmaceuticals Major Business
Table 61. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Product and Services
Table 62. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Santhera Pharmaceuticals Recent Developments/Updates
Table 64. Sarepta Therapeutics, Inc. Basic Information, Area Served and Competitors
Table 65. Sarepta Therapeutics, Inc. Major Business
Table 66. Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Product and Services
Table 67. Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 68. Global Key Players of Duchenne Muscular Dystrophy Treatment Upstream (Raw Materials)
Table 69. Duchenne Muscular Dystrophy Treatment Typical Customers
Table 1. World Duchenne Muscular Dystrophy Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Duchenne Muscular Dystrophy Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Duchenne Muscular Dystrophy Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Duchenne Muscular Dystrophy Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Duchenne Muscular Dystrophy Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Duchenne Muscular Dystrophy Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Duchenne Muscular Dystrophy Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Duchenne Muscular Dystrophy Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Duchenne Muscular Dystrophy Treatment Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Duchenne Muscular Dystrophy Treatment Players in 2022
Table 12. World Duchenne Muscular Dystrophy Treatment Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Duchenne Muscular Dystrophy Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Duchenne Muscular Dystrophy Treatment Player
Table 15. Duchenne Muscular Dystrophy Treatment Market: Company Product Type Footprint
Table 16. Duchenne Muscular Dystrophy Treatment Market: Company Product Application Footprint
Table 17. Duchenne Muscular Dystrophy Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Duchenne Muscular Dystrophy Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Duchenne Muscular Dystrophy Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Duchenne Muscular Dystrophy Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Duchenne Muscular Dystrophy Treatment Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Duchenne Muscular Dystrophy Treatment Revenue Market Share (2018-2023)
Table 23. China Based Duchenne Muscular Dystrophy Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Duchenne Muscular Dystrophy Treatment Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Duchenne Muscular Dystrophy Treatment Revenue Market Share (2018-2023)
Table 26. Rest of World Based Duchenne Muscular Dystrophy Treatment Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Duchenne Muscular Dystrophy Treatment Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Duchenne Muscular Dystrophy Treatment Revenue Market Share (2018-2023)
Table 29. World Duchenne Muscular Dystrophy Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Duchenne Muscular Dystrophy Treatment Market Size by Type (2018-2023) & (USD Million)
Table 31. World Duchenne Muscular Dystrophy Treatment Market Size by Type (2024-2029) & (USD Million)
Table 32. World Duchenne Muscular Dystrophy Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Duchenne Muscular Dystrophy Treatment Market Size by Application (2018-2023) & (USD Million)
Table 34. World Duchenne Muscular Dystrophy Treatment Market Size by Application (2024-2029) & (USD Million)
Table 35. ITALFARMACO SpA Basic Information, Area Served and Competitors
Table 36. ITALFARMACO SpA Major Business
Table 37. ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Product and Services
Table 38. ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. ITALFARMACO SpA Recent Developments/Updates
Table 40. ITALFARMACO SpA Competitive Strengths & Weaknesses
Table 41. FibroGen, Inc. Basic Information, Area Served and Competitors
Table 42. FibroGen, Inc. Major Business
Table 43. FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Product and Services
Table 44. FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. FibroGen, Inc. Recent Developments/Updates
Table 46. FibroGen, Inc. Competitive Strengths & Weaknesses
Table 47. Summit Therapeuticsplc Basic Information, Area Served and Competitors
Table 48. Summit Therapeuticsplc Major Business
Table 49. Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Product and Services
Table 50. Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Summit Therapeuticsplc Recent Developments/Updates
Table 52. Summit Therapeuticsplc Competitive Strengths & Weaknesses
Table 53. PTC Therapeutics Basic Information, Area Served and Competitors
Table 54. PTC Therapeutics Major Business
Table 55. PTC Therapeutics Duchenne Muscular Dystrophy Treatment Product and Services
Table 56. PTC Therapeutics Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. PTC Therapeutics Recent Developments/Updates
Table 58. PTC Therapeutics Competitive Strengths & Weaknesses
Table 59. Santhera Pharmaceuticals Basic Information, Area Served and Competitors
Table 60. Santhera Pharmaceuticals Major Business
Table 61. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Product and Services
Table 62. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Santhera Pharmaceuticals Recent Developments/Updates
Table 64. Sarepta Therapeutics, Inc. Basic Information, Area Served and Competitors
Table 65. Sarepta Therapeutics, Inc. Major Business
Table 66. Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Product and Services
Table 67. Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 68. Global Key Players of Duchenne Muscular Dystrophy Treatment Upstream (Raw Materials)
Table 69. Duchenne Muscular Dystrophy Treatment Typical Customers
LIST OF FIGURES
Figure 1. Duchenne Muscular Dystrophy Treatment Picture
Figure 2. World Duchenne Muscular Dystrophy Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Duchenne Muscular Dystrophy Treatment Total Market Size (2018-2029) & (USD Million)
Figure 4. World Duchenne Muscular Dystrophy Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Duchenne Muscular Dystrophy Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Duchenne Muscular Dystrophy Treatment Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Duchenne Muscular Dystrophy Treatment Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Duchenne Muscular Dystrophy Treatment Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Duchenne Muscular Dystrophy Treatment Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Duchenne Muscular Dystrophy Treatment Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Duchenne Muscular Dystrophy Treatment Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Duchenne Muscular Dystrophy Treatment Revenue (2018-2029) & (USD Million)
Figure 13. Duchenne Muscular Dystrophy Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 16. World Duchenne Muscular Dystrophy Treatment Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. China Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. India Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Duchenne Muscular Dystrophy Treatment by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Duchenne Muscular Dystrophy Treatment Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Duchenne Muscular Dystrophy Treatment Markets in 2022
Figure 27. United States VS China: Duchenne Muscular Dystrophy Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Duchenne Muscular Dystrophy Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Duchenne Muscular Dystrophy Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Duchenne Muscular Dystrophy Treatment Market Size Market Share by Type in 2022
Figure 31. NSAIDs
Figure 32. Corticosteroids
Figure 33. Others
Figure 34. World Duchenne Muscular Dystrophy Treatment Market Size Market Share by Type (2018-2029)
Figure 35. World Duchenne Muscular Dystrophy Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Duchenne Muscular Dystrophy Treatment Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Clinic
Figure 39. Others
Figure 40. Duchenne Muscular Dystrophy Treatment Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Duchenne Muscular Dystrophy Treatment Picture
Figure 2. World Duchenne Muscular Dystrophy Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Duchenne Muscular Dystrophy Treatment Total Market Size (2018-2029) & (USD Million)
Figure 4. World Duchenne Muscular Dystrophy Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Duchenne Muscular Dystrophy Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Duchenne Muscular Dystrophy Treatment Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Duchenne Muscular Dystrophy Treatment Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Duchenne Muscular Dystrophy Treatment Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Duchenne Muscular Dystrophy Treatment Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Duchenne Muscular Dystrophy Treatment Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Duchenne Muscular Dystrophy Treatment Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Duchenne Muscular Dystrophy Treatment Revenue (2018-2029) & (USD Million)
Figure 13. Duchenne Muscular Dystrophy Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 16. World Duchenne Muscular Dystrophy Treatment Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. China Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. India Duchenne Muscular Dystrophy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Duchenne Muscular Dystrophy Treatment by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Duchenne Muscular Dystrophy Treatment Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Duchenne Muscular Dystrophy Treatment Markets in 2022
Figure 27. United States VS China: Duchenne Muscular Dystrophy Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Duchenne Muscular Dystrophy Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Duchenne Muscular Dystrophy Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Duchenne Muscular Dystrophy Treatment Market Size Market Share by Type in 2022
Figure 31. NSAIDs
Figure 32. Corticosteroids
Figure 33. Others
Figure 34. World Duchenne Muscular Dystrophy Treatment Market Size Market Share by Type (2018-2029)
Figure 35. World Duchenne Muscular Dystrophy Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Duchenne Muscular Dystrophy Treatment Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Clinic
Figure 39. Others
Figure 40. Duchenne Muscular Dystrophy Treatment Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
